|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ye DW, Eto M, Chung JS, Kimura G, Chang
W-C, Chang Y-H, Pang S-T, Lee JL, Niu Y, Gurney H, et al: Use of
targeted therapies for advanced renal cell carcinoma in the
Asia-Pacific region: Opinion statement from China, Japan, Taiwan,
Korea, and Australia. Clin Genitourin Cancer. 12:225–233. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Patel AR, Prasad SM, Shih YC and Eggener
SE: The association of the human development index with global
kidney cancer incidence and mortality. J Urol. 187:1978–1983. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Delahunt B: Advances and controversies in
grading and staging of renal cell carcinoma. Mod Pathol. 22:(Suppl
2). S24–S36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Motzer RJ, Escudier B, Oudard S, Hutson
TE, Porta C, Bracarda S, Grünwald V, Thompson JA, Figlin RA,
Hollaender N, et al: Phase 3 trial of everolimus for metastatic
renal cell carcinoma: Final results and analysis of prognostic
factors. Cancer. 116:4256–4265. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sternberg CN, Davis ID, Mardiak J,
Szczylik C, Lee E, Wagstaff J, Barrios CH, Salman P, Gladkov OA,
Kavina A, et al: Pazopanib in locally advanced or metastatic renal
cell carcinoma: Results of a randomized phase III trial. J Clin
Oncol. 28:1061–1068. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rini BI, Escudier B, Tomczak P, Kaprin A,
Szczylik C, Hutson TE, Michaelson MD, Gorbunova VA, Gore ME,
Rusakov IG, et al: Comparative effectiveness of axitinib versus
sorafenib in advanced renal cell carcinoma (AXIS): A randomised
phase 3 trial. Lancet. 378:1931–1939. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mancini V, Battaglia M, Ditonno P, Palazzo
S, Lastilla G, Montironi R, Bettocchi C, Cavalcanti E, Ranieri E
and Selvaggi FP: Current insights in renal cell cancer pathology.
Urol Oncol. 26:225–238. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Larjava H, Plow EF and Wu C: Kindlins:
Essential regulators of integrin signalling and cell-matrix
adhesion. EMBO Rep. 9:1203–1208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tu Y, Wu S, Shi X, Chen K and Wu C:
Migfilin and Mig-2 link focal adhesions to filamin and the actin
cytoskeleton and function in cell shape modulation. Cell.
113:37–47. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gong X, An Z, Wang Y, Guan L, Fang W,
Strömblad S, Jiang Y and Zhang H: Kindlin-2 controls sensitivity of
prostate cancer cells to cisplatin-induced cell death. Cancer Lett.
299:54–62. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen Z, Ye Y, Dong L, Vainionpää S,
Mustonen H, Puolakkainen P and Wang S: Kindlin-2: A novel adhesion
protein related to tumor invasion, lymph node metastasis, and
patient outcome in gastric cancer. Am J Surg. 203:222–229. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Talaat S, Somji S, Toni C, Garrett SH,
Zhou XD, Sens MA and Sens DA: Kindlin-2 expression in arsenite- and
cadmium-transformed bladder cancer cell lines and in archival
specimens of human bladder cancer. Urology. 77:1507.e1–7. 2011.
View Article : Google Scholar
|
|
14
|
Zhan J, Zhu X, Guo Y, Wang Y, Wang Y,
Qiang G, Niu M, Hu J, Du J, Li Z, et al: Opposite role of Kindlin-1
and Kindlin-2 in lung cancers. PLoS One. 7:e503132012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
An Z, Dobra K, Lock JG, Stromblad S,
Hjerpe A and Zhang H: Kindlin-2 is expressed in malignant
mesothelioma and is required for tumor cell adhesion and migration.
Int J Cancer. 127:1999–2008. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu Y, Wu J, Wang Y, Zhao T, Ma B, Liu Y,
Fang W, Zhu W-G and Zhang H: Kindlin 2 forms a transcriptional
complex with beta-catenin and TCF4 to enhance Wnt signalling. EMBO
Rep. 13:750–758. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ren C, Du J, Xi C, Yu Y, Hu A, Zhan J, Guo
H, Fang W, Liu C and Zhang H: Kindlin-2 inhibits serous epithelial
ovarian cancer peritoneal dissemination and predicts patient
outcomes. Biochem Biophys Res Commun. 446:187–194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi X and Wu C: A suppressive role of
mitogen inducible gene-2 in mesenchymal cancer cell invasion. Mol
Cancer Res. 6:715–724. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao T, Guan L, Yu Y, Pei X, Zhan J, Han
L, Tang Y, Li F, Fang W and Zhang H: Kindlin-2 promotes genome
instability in breast cancer cells. Cancer Lett. 330:208–216. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fukuda K, Bledzka K, Yang J, Perera HD,
Plow EF and Qin J: Molecular basis of Kindlin-2 binding to
integrin-linked kinase pseudokinase for regulating cell adhesion. J
Biol Chem. 289:28363–28375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huet-Calderwood C, Brahme NN, Kumar N,
Stiegler AL, Raghavan S, Boggon TJ and Calderwood DA: Differences
in binding to the ILK complex determines kindlin isoform adhesion
localization and integrin activation. J Cell Sci. 127:4308–4321.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan M, Zhang L, Wu Y, Gao L, Yang W, Li J,
Chen Y and Jin X: Increased expression of Kindlin-2 is correlated
with hematogenous metastasis and poor prognosis in patients with
clear cell renal cell carcinoma. FEBS Open Bio. 6:660–665. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhan J, Yang M, Chi X, Zhang J, Pei XL,
Ren CX, Guo YQ, Liu W and Zhang HQ: Kindlin-2 expression in adult
tissues correlates with their embryonic origins. Sci China Life
Sci. 57:690–697. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu Y, Wu J, Guan L, Qi L, Tang Y, Ma B,
Zhan J, Wang Y, Fang W and Zhang H: Kindlin 2 promotes breast
cancer invasion via epigenetic silencing of the microRNA200 gene
family. Int J Cancer. 133:1368–1379. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen Z, Ye Y, Kauttu T, Seppänen H,
Vainionpää S, Wang S, Mustonen H and Puolakkainen P: The novel
focal adhesion gene Kindlin-2 promotes the invasion of gastric
cancer cells mediated by tumor-associated macrophages. Oncol Rep.
29:791–797. 2013.PubMed/NCBI
|
|
26
|
Shen Z, Ye Y, Kauttu T, Seppänen H,
Vainionpää S, Wang S, Mustonen H and Puolakkainen P: Novel focal
adhesion protein Kindlin-2 promotes the invasion of gastric cancer
cells through phosphorylation of integrin beta1 and beta3. J Surg
Oncol. 108:106–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang HF, Zhang K, Liao LD, Li L-Y, Du
Z-P, Wu B-L, Wu J-Y, Xu X-E, Zeng F-M, Chen B, et al: miR-200b
suppresses invasiveness and modulates the cytoskeletal and adhesive
machinery in esophageal squamous cell carcinoma cells via targeting
Kindlin-2. Carcinogenesis. 35:292–301. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhan J, Song J, Wang P, Chi X, Wang Y, Guo
Y, Fang W and Zhang H: Kindlin-2 induced by TGF-beta signaling
promotes pancreatic ductal adenocarcinoma progression through
downregulation of transcriptional factor HOXB9. Cancer Lett.
361:75–85. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ren Y, Jin H, Xue Z, Xu Q, Wang S, Zhao G,
Huang J and Huang H: Kindlin-2 inhibited the growth and migration
of colorectal cancer cells. Tumour Biol. 36:4107–4114. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Niehrs C: Function and biological roles of
the Dickkopf family of Wnt modulators. Oncogene. 25:7469–7481.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hsu RJ, Ho JY, Cha TL, Yu D-S, Wu C-L,
Huang W-P, Chu P, Chen Y-H, Chen J-T and Yu C-P: WNT10A plays an
oncogenic role in renal cell carcinoma by activating
WNT/beta-catenin pathway. PLoS One. 7:e476492012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saadi-Kheddouci S, Berrebi D, Romagnolo B,
Cluzeaud F, Peuchmaur M, Kahn A, Vandewalle A and Perret C: Early
development of polycystic kidney disease in transgenic mice
expressing an activated mutant of the beta-catenin gene. Oncogene.
20:5972–5981. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peruzzi B, Athauda G and Bottaro DP: The
von Hippel-Lindau tumor suppressor gene product represses oncogenic
beta-catenin signaling in renal carcinoma cells. Proc Natl Acad Sci
USA. 103:14531–14536. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Von Schulz-Hausmann SA, Schmeel LC,
Schmeel FC and Schmidt-Wolf IG: Targeting the Wnt/beta-catenin
pathway in renal cell carcinoma. Anticancer Res. 34:4101–4108.
2014.PubMed/NCBI
|
